DGAP-News: M1 Kliniken AG increases sales and profits in 2018 and is on the way to becoming number 1 in beauty in Europe
DGAP-News: M1 Kliniken AG / Key word(s): Preliminary Results
M1 Kliniken AG increases sales and profits in 2018 and is on the way to becoming number 1 in beauty in Europe
04.06.2019 / 12:11
The issuer is solely responsible for the content of this announcement.
M1 Kliniken AG increases sales and profits in 2018 and is on the way to becoming number 1 in beauty in Europe
- Preliminary figures 2018: Sales 65.2 million euros (+38 %), EBT 8.1 million euros (+10 %)
- Positive outlook: sales and earnings to be further increased
Berlin, 04.06.2019 - M1 Kliniken AG (ISIN: DE000A0STSQ8) has continued its profitable growth path in 2018 and invested considerably in further expansion. In the 2018 financial year, the M1 Group increased sales by a good 38% year-on-year to EUR 65.2 million (preliminary figures). Despite the start-up costs of the numerous new locations, the training and further education of the more than 60 doctors at the M1 Academy as well as investments in new fields of treatment and markets, profit again increased in 2018. The pre-tax result from ordinary activities (EBT) increased by more than 10 % to 8.1 million euros.
"In 2018, we expanded our market leadership in Germany and, with "M1 Laser" and "M1 Dental", expanded our range of services to include dermatological laser and aesthetic dental treatments," says Patrick Brenske, CEO of M1 Kliniken AG. "In Germany and practically every other country in Western Europe, we have considerable growth opportunities. In the coming years we want to make consistent use of these opportunities and are thus on the way to further developing M1 to the number 1 in terms of beauty in Europe". In addition to Dortmund and a further location in Hamburg, M1 plans new openings in Linz, Zurich and Amsterdam in the coming months. This will boost the international expansion.
Overall, M1 plans to double the number of "M1 Med Beauty" specialist centres to around 50 by the end of 2020. Around 30 of these will be located in Germany and 20 in other European countries. The integration of "M1 Laser" will further increase the profitability of the locations. In addition, "M1 Dental" will be available throughout Germany.
The audited 2018 financial statements of M1 Kliniken AG will be published at the beginning of July 2019.
About M1 Kliniken AG
M1 Kliniken AG is the leading provider of beauty medicine health services in Germany. In the aesthetic and surgical field, the group offers products and services of the highest quality. Under the brands M1 Med Beauty, M1 Laser and M1 Dental, beauty medical treatments are currently offered at more than 25 locations. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating theatres and 35 beds, is one of the largest and most modern facilities of its kind in Europe. In addition, the Group markets high-quality products to private customers, doctors, pharmacies and wholesalers under the M1 Select and M1 Aesthetics brands. www.m1-kliniken.de
Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Phone: +49 (0)30 347 47 44 14
E-mail: [email protected]
04.06.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
M1 Kliniken AG |
|
Grünauer Straße 5 |
|
12557 Berlin |
|
Germany |
Phone: |
+49 (0)30 347 47 44 14 |
Fax: |
+49 (0)30 347 47 44 17 |
E-mail: |
[email protected] |
Internet: |
https://www.m1-kliniken.de |
ISIN: |
DE000A0STSQ8 |
WKN: |
A0STSQ |
Listed: |
Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart, Tradegate Exchange |
EQS News ID: |
818973 |
|
End of News |
DGAP News Service |
818973 04.06.2019
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
Umsatzerlöse1 |
47,19 |
65,21 |
77,27 |
159,59 |
314,61 |
285,29 |
302,00 |
EBITDA1,2 |
6,18 |
7,17 |
11,33 |
8,89 |
17,82 |
15,41 |
19,85 |
EBITDA-Marge3 |
13,10 |
11,00 |
14,66 |
5,57 |
5,66 |
5,40 |
|
EBIT1,4 |
5,71 |
6,46 |
7,93 |
4,41 |
12,13 |
9,35 |
14,40 |
EBIT-Marge5 |
12,10 |
9,91 |
10,26 |
2,76 |
3,86 |
3,28 |
4,77 |
Jahresüberschuss1 |
5,78 |
6,61 |
9,73 |
7,43 |
10,88 |
7,07 |
9,50 |
Netto-Marge6 |
12,25 |
10,14 |
12,59 |
4,66 |
3,46 |
2,48 |
3,15 |
Cashflow1,7 |
2,09 |
2,86 |
-5,37 |
9,54 |
15,68 |
20,77 |
0,00 |
Ergebnis je Aktie8 |
0,38 |
0,39 |
0,56 |
0,37 |
0,45 |
0,22 |
0,39 |
Dividende8 |
0,30 |
0,30 |
0,00 |
0,00 |
0,00 |
0,00 |
0,30 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2022 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: wetreu NTRG
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
M1 Kliniken |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
A0STSQ |
13,550 |
Kaufen |
266,17 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
19,64 |
28,14 |
0,71 |
35,75 |
KBV |
KCV |
KUV |
EV/EBITDA |
2,72 |
12,82 |
0,93 |
16,55 |
Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
17.07.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
06.06.2024 |
03.09.2024 |
16.11.2023 |
23.05.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
5,84% |
33,60% |
20,98% |
71,52% |
|
|